Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Helix BioMedix Company Description
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States.
It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections.
The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
Helix BioMedix, Inc.
| Country | United States |
| Founded | 1988 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Robin Carmichael |
Contact Details
Address: 22121-17th Avenue SE Bothell, Delaware 98021 United States | |
| Phone | 425-402-8400 |
| Website | helixbiomedix.com |
Stock Details
| Ticker Symbol | HXBM |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US4232875074 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Robin L. Carmichael | President, Chief Executive Officer and Director |